United States Secondary Antibodies Market Report 2017

February 2017 | 116 pages | ID: UC95BD0B584EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Secondary Antibodies

Revenue, means the sales value of Secondary Antibodies

This report studies sales (consumption) of Secondary Antibodies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abnova
• Bio-Rad
• R&D Systems
• Abcam
• MBL
• CST
• Novus Biologicals
• Merk
• PeproTech
• Cayman
• AbMax Biotechnology
• MABTech
• KPL
• BD

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Men'
• Animals'

Split by applications, this report focuses on sales, market share and growth rate of Secondary Antibodies in each application, can be divided into

• ELISA, including many HIV tests
• Western blot
• Immunostaining
• Immunohistochemistry
• Immunocytochemistry

Contents

United States Secondary Antibodies Market Report 2017

1 SECONDARY ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of Secondary Antibodies
1.2 Classification of Secondary Antibodies
  1.2.1 Men'
  1.2.2 Animals'
1.3 Application of Secondary Antibodies
  1.3.1 ELISA, including many HIV tests
  1.3.2 Western blot
  1.3.3 Immunostaining
  1.3.4 Immunohistochemistry
  1.3.5 Immunocytochemistry
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Secondary Antibodies (2012-2022)
  1.4.1 United States Secondary Antibodies Sales and Growth Rate (2012-2022)
  1.4.2 United States Secondary Antibodies Revenue and Growth Rate (2012-2022)

2 UNITED STATES SECONDARY ANTIBODIES COMPETITION BY MANUFACTURERS

2.1 United States Secondary Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Secondary Antibodies Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Secondary Antibodies Average Price by Manufactures (2015 and 2016)
2.4 Secondary Antibodies Market Competitive Situation and Trends
  2.4.1 Secondary Antibodies Market Concentration Rate
  2.4.2 Secondary Antibodies Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SECONDARY ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Secondary Antibodies Sales and Market Share by States (2012-2017)
3.2 United States Secondary Antibodies Revenue and Market Share by States (2012-2017)
3.3 United States Secondary Antibodies Price by States (2012-2017)

4 UNITED STATES SECONDARY ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Secondary Antibodies Sales and Market Share by Type (2012-2017)
4.2 United States Secondary Antibodies Revenue and Market Share by Type (2012-2017)
4.3 United States Secondary Antibodies Price by Type (2012-2017)
4.4 United States Secondary Antibodies Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SECONDARY ANTIBODIES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Secondary Antibodies Sales and Market Share by Application (2012-2017)
5.2 United States Secondary Antibodies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SECONDARY ANTIBODIES MANUFACTURERS PROFILES/ANALYSIS

6.1 Abnova
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Secondary Antibodies Product Type, Application and Specification
    6.1.2.1 Men'
    6.1.2.2 Animals'
  6.1.3 Abnova Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bio-Rad
  6.2.2 Secondary Antibodies Product Type, Application and Specification
    6.2.2.1 Men'
    6.2.2.2 Animals'
  6.2.3 Bio-Rad Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 R&D Systems
  6.3.2 Secondary Antibodies Product Type, Application and Specification
    6.3.2.1 Men'
    6.3.2.2 Animals'
  6.3.3 R&D Systems Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abcam
  6.4.2 Secondary Antibodies Product Type, Application and Specification
    6.4.2.1 Men'
    6.4.2.2 Animals'
  6.4.3 Abcam Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 MBL
  6.5.2 Secondary Antibodies Product Type, Application and Specification
    6.5.2.1 Men'
    6.5.2.2 Animals'
  6.5.3 MBL Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 CST
  6.6.2 Secondary Antibodies Product Type, Application and Specification
    6.6.2.1 Men'
    6.6.2.2 Animals'
  6.6.3 CST Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novus Biologicals
  6.7.2 Secondary Antibodies Product Type, Application and Specification
    6.7.2.1 Men'
    6.7.2.2 Animals'
  6.7.3 Novus Biologicals Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merk
  6.8.2 Secondary Antibodies Product Type, Application and Specification
    6.8.2.1 Men'
    6.8.2.2 Animals'
  6.8.3 Merk Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 PeproTech
  6.9.2 Secondary Antibodies Product Type, Application and Specification
    6.9.2.1 Men'
    6.9.2.2 Animals'
  6.9.3 PeproTech Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cayman
  6.10.2 Secondary Antibodies Product Type, Application and Specification
    6.10.2.1 Men'
    6.10.2.2 Animals'
  6.10.3 Cayman Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 AbMax Biotechnology
6.12 MABTech
6.13 KPL
6.14 BD

7 SECONDARY ANTIBODIES MANUFACTURING COST ANALYSIS

7.1 Secondary Antibodies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Secondary Antibodies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Secondary Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Secondary Antibodies Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SECONDARY ANTIBODIES MARKET FORECAST (2017-2022)

11.1 United States Secondary Antibodies Sales, Revenue Forecast (2017-2022)
11.2 United States Secondary Antibodies Sales Forecast by Type (2017-2022)
11.3 United States Secondary Antibodies Sales Forecast by Application (2017-2022)
11.4 Secondary Antibodies Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Secondary Antibodies
Table Classification of Secondary Antibodies
Figure United States Sales Market Share of Secondary Antibodies by Type in 2015
Figure Men' Picture
Figure Animals' Picture
Table Application of Secondary Antibodies
Figure United States Sales Market Share of Secondary Antibodies by Application in 2015
Figure ELISA, including many HIV tests Examples
Figure Western blot Examples
Figure Immunostaining Examples
Figure Immunohistochemistry Examples
Figure Immunocytochemistry Examples
Figure United States Secondary Antibodies Sales and Growth Rate (2012-2022)
Figure United States Secondary Antibodies Revenue and Growth Rate (2012-2022)
Table United States Secondary Antibodies Sales of Key Manufacturers (2015 and 2016)
Table United States Secondary Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Secondary Antibodies Sales Share by Manufacturers
Figure 2016 Secondary Antibodies Sales Share by Manufacturers
Table United States Secondary Antibodies Revenue by Manufacturers (2015 and 2016)
Table United States Secondary Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Secondary Antibodies Revenue Share by Manufacturers
Table 2016 United States Secondary Antibodies Revenue Share by Manufacturers
Table United States Market Secondary Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Secondary Antibodies Average Price of Key Manufacturers in 2015
Figure Secondary Antibodies Market Share of Top 3 Manufacturers
Figure Secondary Antibodies Market Share of Top 5 Manufacturers
Table United States Secondary Antibodies Sales by States (2012-2017)
Table United States Secondary Antibodies Sales Share by States (2012-2017)
Figure United States Secondary Antibodies Sales Market Share by States in 2015
Table United States Secondary Antibodies Revenue and Market Share by States (2012-2017)
Table United States Secondary Antibodies Revenue Share by States (2012-2017)
Figure Revenue Market Share of Secondary Antibodies by States (2012-2017)
Table United States Secondary Antibodies Price by States (2012-2017)
Table United States Secondary Antibodies Sales by Type (2012-2017)
Table United States Secondary Antibodies Sales Share by Type (2012-2017)
Figure United States Secondary Antibodies Sales Market Share by Type in 2015
Table United States Secondary Antibodies Revenue and Market Share by Type (2012-2017)
Table United States Secondary Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Secondary Antibodies by Type (2012-2017)
Table United States Secondary Antibodies Price by Type (2012-2017)
Figure United States Secondary Antibodies Sales Growth Rate by Type (2012-2017)
Table United States Secondary Antibodies Sales by Application (2012-2017)
Table United States Secondary Antibodies Sales Market Share by Application (2012-2017)
Figure United States Secondary Antibodies Sales Market Share by Application in 2015
Table United States Secondary Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States Secondary Antibodies Sales Growth Rate by Application (2012-2017)
Table Abnova Basic Information List
Table Abnova Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abnova Secondary Antibodies Sales Market Share (2012-2017)
Table Bio-Rad Basic Information List
Table Bio-Rad Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bio-Rad Secondary Antibodies Sales Market Share (2012-2017)
Table R&D Systems Basic Information List
Table R&D Systems Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table R&D Systems Secondary Antibodies Sales Market Share (2012-2017)
Table Abcam Basic Information List
Table Abcam Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abcam Secondary Antibodies Sales Market Share (2012-2017)
Table MBL Basic Information List
Table MBL Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table MBL Secondary Antibodies Sales Market Share (2012-2017)
Table CST Basic Information List
Table CST Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table CST Secondary Antibodies Sales Market Share (2012-2017)
Table Novus Biologicals Basic Information List
Table Novus Biologicals Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novus Biologicals Secondary Antibodies Sales Market Share (2012-2017)
Table Merk Basic Information List
Table Merk Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merk Secondary Antibodies Sales Market Share (2012-2017)
Table PeproTech Basic Information List
Table PeproTech Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table PeproTech Secondary Antibodies Sales Market Share (2012-2017)
Table Cayman Basic Information List
Table Cayman Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cayman Secondary Antibodies Sales Market Share (2012-2017)
Table AbMax Biotechnology Basic Information List
Table MABTech Basic Information List
Table KPL Basic Information List
Table BD Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Secondary Antibodies
Figure Manufacturing Process Analysis of Secondary Antibodies
Figure Secondary Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Secondary Antibodies Major Manufacturers in 2015
Table Major Buyers of Secondary Antibodies
Table Distributors/Traders List
Figure United States Secondary Antibodies Production and Growth Rate Forecast (2017-2022)
Figure United States Secondary Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table United States Secondary Antibodies Production Forecast by Type (2017-2022)
Table United States Secondary Antibodies Consumption Forecast by Application (2017-2022)
Table United States Secondary Antibodies Sales Forecast by States (2017-2022)
Table United States Secondary Antibodies Sales Share Forecast by States (2017-2022)